A double-blind sham-controlled study found NCAA D1 football players using Vielight showed a strikingly different brain MRI profile after a full 16-week season.
Published in Brain Stimulation (n=45): Vielight intranasal PBM triggered CSF changes in 4 minutes, using ~5% of the energy required by transcranial delivery.
Independent MRI and fMRI studies suggest Vielight’s tech may influence large-scale brain networks, changes in perfusion, connectivity, and network efficiency.
An n=30 fMRI study shows Vielight's intranasal-transcranial photobiomodulation (itPBM) improves cerebellar network efficiency and segregation in TBI athletes.
This TBI study (n=44) with the Vielight Neuro is the largest successful PBM trial showing significant objective cognitive gains in the brain PBM field.
A Nature Scientific Reports study marks the only high-level journal publication demonstrating direct EEG neuromodulation with a commercial brain PBM device.
A University of Utah n = 43 trial shows Vielight Neuro itPBM significantly improves reaction time, bilateral grip strength, and postural balance in athletes.
Health Canada expands the Vielight RX Plus medical device license to cover upper respiratory symptom recovery for all viral infections based on an n=294 RCT.
Vielight is featured in research that suggests anti-brain aging mechanisms by optimizing cognition, optimizing mitochondrial ATP, systemic immunity, and HRV.
Watch the physics of full transcranial coverage: See how Neuro volumetric diffusion focuses on major brain networks while the intranasal module targets deep structures.
Live in Toronto with MCI? Join the University of Toronto clinical trial evaluating the Vielight Neuro RX Gamma for memory changes and mild cognitive decline.
Medical expert Dr. Cody Rall, MD, reviews Vielight technology from a US Navy psychiatrist’s perspective, analyzing its objective impact on brain health and focus.